Loewen Andrea
Officer at REATA PHARMACEUTICALS INC
- Sold, on record
- $2.9M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Sep 14, 2023
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- REATA PHARMACEUTICALS INCOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale REATA PHARMACEUTICALS INCPlan not statedMar 3 2023
Sold 1,819 shares at $88.08 ($160k)
Loewen Andrea, SVP, Global Regulatory Affairs
Sold 4.1% of holdings ($3.9M position)42,793 shares leftFirst sale on recordFiling
- 2 Form 4 sale REATA PHARMACEUTICALS INCUnusualMar 7 +4 days
Sold 19,036 shares at $83.43 ($1.6M)
Loewen Andrea, SVP, Global Regulatory Affairs
Sold 32.9% of holdings ($4.8M position)38,757 shares leftFiling
- 3 Form 144 notice REATA PHARMACEUTICALS INCNoticeMay 12 +66 days
Filed to sell 6,750 shares ($582k)
Loewen Andrea, Officer
No 10b5-1 planFiling
- 4 Form 144 notice REATA PHARMACEUTICALS INCNoticeMay 15 +3 days
Filed to sell 103 shares ($9k)
Loewen Andrea, Officer
No 10b5-1 planFiling
- 5 Form 4 sale REATA PHARMACEUTICALS INCNo planMay 16 +1 day
Sold 7,166 shares at $86.01 ($616k)
Loewen Andrea, SVP, Global Regulatory Affairs
No 10b5-1 planSold 18.5% of holdings ($3.3M position)31,591 shares leftFollows a Form 144Filing
- 6 Form 144 notice REATA PHARMACEUTICALS INCNoticeMay 16 same day
Filed to sell 313 shares ($25k)
Loewen Andrea, Officer
No 10b5-1 planFiling
- 7 Form 144 notice REATA PHARMACEUTICALS INCNoticeSep 14 +121 days
Filed to sell 3,175 shares ($546k)
Loewen Andrea, Officer
No 10b5-1 plan0.4x usual sizeFiling
- 8 Form 4 sale REATA PHARMACEUTICALS INCNo planSep 14 same day
Sold 3,175 shares at $172.03 ($546k)
Loewen Andrea, SVP, Global Regulatory Affairs
No 10b5-1 planSold 10.1% of holdings ($5.4M position)28,416 shares left0.4x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (8)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 | REATA PHARMACEUTICALS INC | SVP, Global Regulatory Affairs | Form 4 sale | 3,175 | $546k | 10.1% | No plan | SEC |
| Sep 14, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 3,175 | $546k | Notice | SEC | |
| May 16, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 313 | $25k | Notice | SEC | |
| May 16, 2023 | REATA PHARMACEUTICALS INC | SVP, Global Regulatory Affairs | Form 4 sale | 7,166 | $616k | 18.5% | No plan | SEC |
| May 15, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 103 | $9k | Notice | SEC | |
| May 12, 2023 | REATA PHARMACEUTICALS INC | Officer | Form 144 notice | 6,750 | $582k | Notice | SEC | |
| Mar 7, 2023 | REATA PHARMACEUTICALS INC | SVP, Global Regulatory Affairs | Form 4 sale | 19,036 | $1.6M | 32.9% | Unusual | SEC |
| Mar 3, 2023 | REATA PHARMACEUTICALS INC | SVP, Global Regulatory Affairs | Form 4 sale | 1,819 | $160k | 4.1% | Plan not stated | SEC |